Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.
Liu G, Yang W, Guo M, Liu X, Huang N, Li D, Jiang Z, Yang W, Zhang W, Su H, Liu Z, Liu T, Wang D, Huang S, Yao B, Man Q, Qiu L, Sun X, Sun Y, Liu B.
Liu G, et al. Among authors: guo m.
Cancer Immunol Immunother. 2012 Dec;61(12):2357-66. doi: 10.1007/s00262-012-1297-2. Epub 2012 Jun 22.
Cancer Immunol Immunother. 2012.
PMID: 22722448
Free PMC article.